Literature DB >> 24511032

Is gastric tube reconstruction the optimal surgical procedure for Siewert type II esophagogastric junction carcinoma?

Minoru Fukuchi1, Erito Mochiki, Okihide Suzuki, Toru Ishiguro, Jun Sobajima, Kana Saito, Hiroshi Naitoh, Youichi Kumagai, Hiroyuki Baba, Keiichiro Ishibashi, Hideyuki Ishida.   

Abstract

BACKGROUND/AIM: To evaluate the potential risk of gastric tube reconstruction for Siewert type II esophagogastric junction carcinoma. PATIENTS AND METHODS: We retrospectively analyzed clinicopathological and survival data of 41 patients who had undergone total gastrectomy for Siewert type II carcinoma, focusing on lymph node metastasis around the middle to lower greater curvature or parapyloric area.
RESULTS: Histological examination showed involvement of at least one lymph node in six patients (14%). Multivariate Cox proportional hazard regression analysis of seven clinicopathological variables showed that lymph node metastasis around the middle to lower greater curvature, or parapyloric area was the only significant independent unfavorable factor (odds ratio=6.62; 95% confidence interval=1.27-41.1; p=0.03) for survival. We identified no significant predictors of lymph node metastasis in analyzed patients.
CONCLUSION: From an oncological point of view, we do not recommend routine gastric tube reconstruction for Siewert type II carcinoma.

Entities:  

Keywords:  Esophagogastric junction carcinoma; Siewert type II; gastric tube reconstruction

Mesh:

Year:  2014        PMID: 24511032

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

Review 1.  Outcomes for jejunal interposition reconstruction compared with Roux-en-Y anastomosis: A meta-analysis.

Authors:  Kai-Xi Fan; Zhong-Fa Xu; Mei-Rong Wang; Dao-Tang Li; Xiang-Shan Yang; Jing Guo
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

2.  Isoperistaltic Jejunal Loop Interposition after Total Gastrectomy for Gastric Cancer in Patients with Familial Adenomatous Polyposis.

Authors:  Matteo Zuin; Francesco Celotto; Salvatore Pucciarelli; Emanuele Damiano Luca Urso
Journal:  J Gastric Cancer       Date:  2020-04-13       Impact factor: 3.720

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.